METHODS	VEDERA will recruit 120 patients with early , treatment-nave RA , randomized to TNFi therapy etanercept ( ETN ) combined with methotrexate ( MTX ) , or therapy with MTX with or without additional synthetic disease modifying anti-rheumatic drugs with escalation to ETN following a ` treat-to-target ' regimen .\